BALVERSA® (erdafitinib)
- Interactive Ingredient Checker
- Pivotal Clinical Trial Publications
- Search Medical Information
- U.S. FDA Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations
- Useful Links